Dongjun Peng

2.6k total citations · 1 hit paper
7 papers, 1.5k citations indexed

About

Dongjun Peng is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dongjun Peng has authored 7 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Dongjun Peng's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Dongjun Peng is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Dongjun Peng collaborates with scholars based in United States, China and Poland. Dongjun Peng's co-authors include Weiping Zou, Ilona Kryczek, Nisha Nagarsheth, Wojciech Szeliga, Linda Vatan, Lili Zhao, Ende Zhao, Yali Dou, Shuang Wei and Weimin Wang and has published in prestigious journals such as Nature, Immunity and The Journal of Immunology.

In The Last Decade

Dongjun Peng

7 papers receiving 1.5k citations

Hit Papers

Epigenetic silencing of TH1-type chemokines shapes tumour... 2015 2026 2018 2022 2015 250 500 750

Peers

Dongjun Peng
Natalie B. Collins United States
Mary Litzinger United States
Andrew J. Gunderson United States
Jan L. Fisher United States
Frank M. Speetjens Netherlands
Yansen Li China
Yuan Mao China
Natalie B. Collins United States
Dongjun Peng
Citations per year, relative to Dongjun Peng Dongjun Peng (= 1×) peers Natalie B. Collins

Countries citing papers authored by Dongjun Peng

Since Specialization
Citations

This map shows the geographic impact of Dongjun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongjun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongjun Peng more than expected).

Fields of papers citing papers by Dongjun Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongjun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongjun Peng. The network helps show where Dongjun Peng may publish in the future.

Co-authorship network of co-authors of Dongjun Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Dongjun Peng. A scholar is included among the top collaborators of Dongjun Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongjun Peng. Dongjun Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Kryczek, Ilona, Dongjun Peng, Nisha Nagarsheth, et al.. (2016). Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. The Journal of Immunology. 196(1_Supplement). 213.20–213.20. 14 indexed citations
2.
Nagarsheth, Nisha, Dongjun Peng, Ilona Kryczek, et al.. (2015). PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Research. 76(2). 275–282. 213 indexed citations
3.
Peng, Dongjun, Ilona Kryczek, Nisha Nagarsheth, et al.. (2015). Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 527(7577). 249–253. 893 indexed citations breakdown →
4.
Sun, Danfeng, Yanwei Lin, Jie Hong, et al.. (2015). Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling. OncoImmunology. 5(8). e1082704–e1082704. 31 indexed citations
5.
Kryczek, Ilona, Yanwei Lin, Nisha Nagarsheth, et al.. (2015). IL-22+CD4+ T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L (TUM10P.1022). The Journal of Immunology. 194(1_Supplement). 211.3–211.3. 2 indexed citations
6.
Kryczek, Ilona, Yanwei Lin, Nisha Nagarsheth, et al.. (2014). IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L. Immunity. 40(5). 772–784. 297 indexed citations
7.
Sun, Jun, Ying Yan, Xiaowen Liu, et al.. (2009). PTD4‐apoptin protein therapy inhibits tumor growth in vivo. International Journal of Cancer. 124(12). 2973–2981. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026